Qualified Participants Must:
You are being asked to join this study because you may have hypogonadism (a condition where low blood testosterone levels are associated with clinical symptoms)
Qualified Participants May Receive:
Neither you nor your insurance company will have to pay for the study drug (AndroGel 1.62% or placebo) or procedures that are done only for the study.
You may be paid $85.00 for each completed office visit with the exception of Screening Visit 3, if necessary: $50.00.